• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Drug-eluting Stents: No Benefit in Vein Grafts

  • — 17 Nov, 2005
AudioMedica News
AudioMedica News
Drug-eluting Stents: No Benefit in Vein Grafts
Drug-eluting Stents: No Benefit in Vein Grafts
00:00 /
RSS Feed
Share
Link
Embed

Drug-eluting stents should not be the favoured option for treating saphenous vein graft lesions according conclusions from a registry analysis presented to the American Heart Association conference by Jeff Trost from Johns Hopkins in Baltimore.
[audio:https://www.audiomedica.com/podcasting/aha2005/Jeff_Trost.mp3]

Click here for all the interviews from AHA 2005

You may also like...

  • Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006 Audio Journal of Cardiovascular Medicine: reporting from American Heart Association Scientific Sessions, Chicago, November 12-15, 2006 13 Nov, 2006
  • Intensive Glycaemic Control: Meta Analysis Confirms Benefit In Type II Diabetes Intensive Glycaemic Control: Meta Analysis Confirms Benefit In Type II Diabetes 23 Jun, 2009
  • Protective Cardiovascular Benefit for Women on HRT For Natural Menopause Protective Cardiovascular Benefit for Women on HRT For Natural Menopause 6 Nov, 2007
  • Timothy Brighton Important new role for aspirin: prevention of recurrent thromboembolism: ASPIRE findings 12 Nov, 2012
  • Previous story Human Growth Hormone: Responses in Severe Heart Failure
  • Next story Engineered Blood Vessels Coming down the Pipe
  • News

    • Liquid Biopsy ctDNA Prediction of Lung Cancer Relapse “Ready for Prime Time”Liquid Biopsy ctDNA Prediction of Lung Cancer Relapse “Ready for Prime Time”August 4, 2022
    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
  • Related interviews

    • Microbiome Diversity Key To Survival After Allogeneic…
    • Ibrutinib: New Frontline Standard for Chronic Lymphocytic…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • New Front Line Standard for Older Patients with Chronic…
    • How Babies Use Object Permanence To Get What They Want
  • Home
  • Cardiovascular
  • AHA 2005
  • Drug-eluting Stents: No Benefit in Vein Grafts

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.